SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (163)10/19/2006 10:44:54 AM
From: tuck  Read Replies (1) | Respond to of 507
 
This was expected, but is probably contributing to today's little swoon.

investorshub.com

Going to write calls until January, then see what happens when PFE is done with education & gets serious about selling the product.

Cheers, Tuck



To: Arthur Radley who wrote (163)10/19/2006 5:06:41 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 507
 
One at least has to appreciate the candor of the new [PFE] CEO.

I’d rather have the old CEO, warts and all. The new guy goes on and on without saying anything that’s not a cliché. He's painful to listen to.

I think Sanofi is pleased they sold their position in the drug to PFE.

Good observation.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News